Earnings Feed
Start Free
|4May 10, 5:24 PM ET

Carle Vanessa 4

4 · Lexaria Bioscience Corp. · Filed May 10, 2024

Insider Transaction Report

Form 4
Period: 2024-04-26
Lexaria Bioscience Corp.LEXX
Carle Vanessa
Secretary
Transactions
  • Award

    Stock Options

    2024-04-26+10,000→ 62,567 total
    Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (10,000 underlying)
Holdings

  • Stock Options

    Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying)
    17,567

  • Stock Options

    Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying)
    27,567

  • Stock Options

    Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (12,500 underlying)
    40,067

  • Stock Options

    Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (12,500 underlying)
    52,567

  • common shares

    67

  • Warrants

    Exercise: $36.00From: 2019-11-13Exp: 2024-11-13→ Common Shares (67 underlying)
    67

  • Stock Options

    Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (12,500 underlying)
    12,567
Footnotes (3)
  • [F1]Repriced from $5.31 pursuant to shareholder approval received May 9, 2023
  • [F2]Repriced from $7.08 pursuant to shareholder approval received May 9, 2023
  • [F3]Repriced from $6.23 pursuant to shareholder approval received May 9, 2023

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT